316 related articles for article (PubMed ID: 20182355)
1. Growth differentiation factor 15 in erythroid health and disease.
Tanno T; Noel P; Miller JL
Curr Opin Hematol; 2010 May; 17(3):184-90. PubMed ID: 20182355
[TBL] [Abstract][Full Text] [Related]
2. [Effect of GDF15 on iron overloading and erythropoiesis].
Zhao YS; Chang CK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):537-41. PubMed ID: 21518525
[TBL] [Abstract][Full Text] [Related]
3. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.
Tanno T; Porayette P; Sripichai O; Noh SJ; Byrnes C; Bhupatiraju A; Lee YT; Goodnough JB; Harandi O; Ganz T; Paulson RF; Miller JL
Blood; 2009 Jul; 114(1):181-6. PubMed ID: 19414861
[TBL] [Abstract][Full Text] [Related]
4. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin.
Tanno T; Bhanu NV; Oneal PA; Goh SH; Staker P; Lee YT; Moroney JW; Reed CH; Luban NL; Wang RH; Eling TE; Childs R; Ganz T; Leitman SF; Fucharoen S; Miller JL
Nat Med; 2007 Sep; 13(9):1096-101. PubMed ID: 17721544
[TBL] [Abstract][Full Text] [Related]
5. Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.
Finkenstedt A; Bianchi P; Theurl I; Vogel W; Witcher DR; Wroblewski VJ; Murphy AT; Zanella A; Zoller H
Br J Haematol; 2009 Mar; 144(5):789-93. PubMed ID: 19120353
[TBL] [Abstract][Full Text] [Related]
6. Iron Status in Newly Diagnosed
Susanah S; Rakhmilla LE; Ghozali M; Trisaputra JO; Moestopo O; Sribudiani Y; Idjradinata PS; Maskoen AM
Biomed Res Int; 2021; 2021():5560319. PubMed ID: 33954177
[TBL] [Abstract][Full Text] [Related]
7. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
[No Abstract] [Full Text] [Related]
8. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.
Tamary H; Shalev H; Perez-Avraham G; Zoldan M; Levi I; Swinkels DW; Tanno T; Miller JL
Blood; 2008 Dec; 112(13):5241-4. PubMed ID: 18824595
[TBL] [Abstract][Full Text] [Related]
9. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin and Anemia: A Tight Relationship.
Pagani A; Nai A; Silvestri L; Camaschella C
Front Physiol; 2019; 10():1294. PubMed ID: 31649559
[TBL] [Abstract][Full Text] [Related]
11. Ineffective Erythropoiesis: Anemia and Iron Overload.
Gupta R; Musallam KM; Taher AT; Rivella S
Hematol Oncol Clin North Am; 2018 Apr; 32(2):213-221. PubMed ID: 29458727
[TBL] [Abstract][Full Text] [Related]
12. Ineffective erythropoiesis and its treatment.
Cazzola M
Blood; 2022 Apr; 139(16):2460-2470. PubMed ID: 34932791
[TBL] [Abstract][Full Text] [Related]
13. Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.
Casanovas G; Swinkels DW; Altamura S; Schwarz K; Laarakkers CM; Gross HJ; Wiesneth M; Heimpel H; Muckenthaler MU
J Mol Med (Berl); 2011 Aug; 89(8):811-6. PubMed ID: 21475976
[TBL] [Abstract][Full Text] [Related]
14. GDF15 expression and iron overload in ineffective erythropoiesis.
Tanno T; Miller JL
Rinsho Ketsueki; 2011 Jun; 52(6):387-98. PubMed ID: 21737991
[No Abstract] [Full Text] [Related]
15. Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.
Cui R; Gale RP; Zhu G; Xu Z; Qin T; Zhang Y; Huang G; Li B; Fang L; Zhang H; Pan L; Hu N; Qu S; Xiao Z
Leuk Res; 2014 May; 38(5):545-50. PubMed ID: 24598841
[TBL] [Abstract][Full Text] [Related]
16. Gdf15 regulates murine stress erythroid progenitor proliferation and the development of the stress erythropoiesis niche.
Hao S; Xiang J; Wu DC; Fraser JW; Ruan B; Cai J; Patterson AD; Lai ZC; Paulson RF
Blood Adv; 2019 Jul; 3(14):2205-2217. PubMed ID: 31324641
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor 15 production is necessary for normal erythroid differentiation and is increased in refractory anaemia with ring-sideroblasts.
Ramirez JM; Schaad O; Durual S; Cossali D; Docquier M; Beris P; Descombes P; Matthes T
Br J Haematol; 2009 Jan; 144(2):251-62. PubMed ID: 19036111
[TBL] [Abstract][Full Text] [Related]
18. Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model.
Artuso I; Lidonnici MR; Altamura S; Mandelli G; Pettinato M; Muckenthaler MU; Silvestri L; Ferrari G; Camaschella C; Nai A
Blood; 2018 Nov; 132(21):2286-2297. PubMed ID: 30209118
[TBL] [Abstract][Full Text] [Related]
19. Megaloblastic anemia-related iron overload and erythroid regulators: a case report.
Vallet N; Delaye JB; Ropert M; Foucault A; Ravalet N; Deriaz S; Chalopin T; Blasco H; Maillot F; Hérault O; Gyan E
J Med Case Rep; 2021 Sep; 15(1):463. PubMed ID: 34538261
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.
Mirciov CS; Wilkins SJ; Dunn LA; Anderson GJ; Frazer DM
PLoS One; 2017; 12(1):e0171054. PubMed ID: 28135344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
